{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T05:10:47Z","timestamp":1785129047832,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018726","name":"Epilepsy Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR200134"],"award-info":[{"award-number":["NIHR200134"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012621","name":"University College London Hospitals Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.yebeh.2024.110215","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T13:59:02Z","timestamp":1734011942000},"page":"110215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The association of polytherapy and psychiatric comorbidity in epilepsy"],"prefix":"10.1016","volume":"163","author":[{"given":"Mercy A.","family":"Odhiambo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert K.","family":"Kaingu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Kipper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josemir W.","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"R.J.C. Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Symon M.","family":"Kariuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2024.110215_b0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.14581\/jer.19002","article-title":"Antiepileptic drug therapy in patients with drug-resistant epilepsy","volume":"9","author":"Park","year":"2019","journal-title":"J Epilepsy Res"},{"key":"10.1016\/j.yebeh.2024.110215_b0010","doi-asserted-by":"crossref","unstructured":"Lee JW, Dworetzky B. Rational Polytherapy with Antiepileptic Drugs. Pharmaceuticals (Basel) 2010;3: 2362-2379.","DOI":"10.3390\/ph3082362"},{"key":"10.1016\/j.yebeh.2024.110215_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2003.09.007","article-title":"Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trial","volume":"57","author":"Beghi","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2024.110215_b0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/14737175.2020.1707668","article-title":"The role of polytherapy in the management of epilepsy: suggestions for rational antiepileptic drug selection","volume":"20","author":"Verrotti","year":"2020","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.yebeh.2024.110215_b0025","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2165\/00003495-200666140-00004","article-title":"Combination therapy in epilepsy: when and what to use","volume":"66","author":"Kwan","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.yebeh.2024.110215_b0030","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1528-1167.2006.00952.x","article-title":"Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments?","volume":"48","author":"Jonker","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.110215_b0035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/1574886314666190311112710","article-title":"Adverse drug reactions of anti-epileptic drugs in children with epilepsy: a cross-sectional study","volume":"14","author":"Kaushik","year":"2019","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.yebeh.2024.110215_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.106947","article-title":"Evaluation of adverse drug reaction profile of antiepileptic drugs in persons with epilepsy: a cross-sectional study","volume":"105","author":"Kumar","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2024.110215_b0045","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.seizure.2005.01.008","article-title":"Complaints associated with the use of antiepileptic drugs: results from a community-based study","volume":"14","author":"Carpay","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2024.110215_b0050","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/epi.17153","article-title":"Association between antiseizure medications and quality of life in epilepsy: a mediation analysis","volume":"63","author":"Wang","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.110215_b0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40360-019-0285-y","article-title":"Adverse drug reactions associated with six commonly used antiepileptic drugs in southern China from 2003 to 2015","volume":"20","author":"Du","year":"2019","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.yebeh.2024.110215_b0060","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yebeh.2017.08.039","article-title":"Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy","volume":"76","author":"Chen","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2024.110215_b0065","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1111\/epi.12741","article-title":"Burden of epilepsy in rural Kenya measured in disability-adjusted life years","volume":"55","author":"Ibinda","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.110215_b0070","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/epi4.12052","article-title":"Magnitude and factors associated with nonadherence to antiepileptic drug treatment in Africa: a cross-sectional multisite study","volume":"2","author":"Ibinda","year":"2017","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2024.110215_b0075","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S2215-0366(16)30403-5","article-title":"Burden, risk factors, and comorbidities of behavioural and emotional problems in Kenyan children: a population-based study","volume":"4","author":"Kariuki","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.yebeh.2024.110215_b0080","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13033-017-0135-5","article-title":"An overview of mental health care system in Kilifi, Kenya: results from an initial assessment using the World Health Organization\u2019s Assessment Instrument for Mental Health Systems","volume":"11","author":"Bitta","year":"2017","journal-title":"Int J Ment Heal Syst"},{"key":"10.1016\/j.yebeh.2024.110215_b0085","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/ije\/dys062","article-title":"Profile: The Kilifi Health and Demographic Surveillance System (KHDSS)","volume":"41","author":"Scott","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.yebeh.2024.110215_b0090","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/epi.12392","article-title":"Clinical features, proximate causes, and consequences of active convulsive epilepsy in Africa","volume":"55","author":"Kariuki","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.110215_b0095","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1186\/1756-0500-6-473","article-title":"Antiepileptic drug utilization in Bangladesh: experience from Dhaka Medical College Hospital","volume":"6","author":"Habib","year":"2013","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.yebeh.2024.110215_b0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.seizure.2020.06.013","article-title":"Epilepsy care cascade, treatment gap and its determinants in rural South Africa","volume":"80","author":"Wagner","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2024.110215_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11073","article-title":"Anti-seizure medications and quality of life in person with epilepsy","volume":"8","author":"Dwivedi","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.yebeh.2024.110215_b0110","article-title":"Comparison of Long-Term Outcomes of Monotherapy and Polytherapy in Seizure-Free Patients With Epilepsy Following Antiseizure Medication Withdrawal","volume":"12","author":"Wang","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2024.110215_b0115","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3906\/sag-2010-27","article-title":"Clinical predictors of drug-resistant epilepsy in children","volume":"51","author":"Karao\u011flu","year":"2021","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.yebeh.2024.110215_b0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/ane.13257","article-title":"Seizure freedom as an outcome in epilepsy treatment clinical trials","volume":"142","author":"Halford","year":"2020","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2024.110215_b0125","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0896-6974(96)00043-6","article-title":"Factors associated with polytherapy in Indian patients with epilepsy","volume":"9","author":"Raghavan","year":"1996","journal-title":"J Epilepsy"},{"key":"10.1016\/j.yebeh.2024.110215_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202613","article-title":"Depression among epileptic patients and its association with drug therapy in sub-Saharan Africa: a systematic review and meta-analysis","volume":"14","author":"Dessie","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.yebeh.2024.110215_b0135","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/aps.2012.135","article-title":"The effect of poor compliance on the pharmacokinetics of carbamazepine and its epoxide metabolite using Monte Carlo simulation","volume":"33","author":"Ding","year":"2012","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.yebeh.2024.110215_b0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0140-6736(97)06250-8","article-title":"Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India","volume":"351","author":"Pal","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2024.110215_b0145","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1586\/ern.09.128","article-title":"Association between attention-deficit\/hyperactivity disorder and epilepsy in pediatric populations","volume":"9","author":"Hamoda","year":"2009","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.yebeh.2024.110215_b0150","first-page":"59","article-title":"Mental disorders induced by carbamazepine","volume":"44","author":"Mizukami","year":"1990","journal-title":"Jpn J Psychiatry Neurol"},{"key":"10.1016\/j.yebeh.2024.110215_b0155","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-244X-12-47","article-title":"Carbamazepine treatment of bipolar disorder: a retrospective evaluation of naturalistic long-term outcomes","volume":"12","author":"Chen","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.yebeh.2024.110215_b0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.yebeh.2011.10.017","article-title":"Behavioral problems in children with epilepsy in rural Kenya","volume":"23","author":"Kariuki","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2024.110215_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107546","article-title":"Aggression as psychiatric side effect of newer AEDs in patients with epilepsy: Cross-sectional study based on buss-perry aggression questionnaire","volume":"115","author":"Kawai","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2024.110215_b0170","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4103\/0019-5545.102436","article-title":"Psychiatric symptomatology, scholastics, and phenytoin","volume":"54","author":"Pandey","year":"2012","journal-title":"Indian J Psychiatry"},{"key":"10.1016\/j.yebeh.2024.110215_b0175","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/0971-6580.172272","article-title":"Psychosis as harbinger of phenytoin toxicity","volume":"22","author":"Borasi","year":"2015","journal-title":"Toxicol Int"},{"key":"10.1016\/j.yebeh.2024.110215_b0180","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2165\/00002018-200730070-00001","article-title":"Negative effects of antiepileptic drugs on mood in patients with epilepsy","volume":"30","author":"Mula","year":"2007","journal-title":"Drug Saf"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505024005973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505024005973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:08:46Z","timestamp":1778616526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505024005973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":36,"alternative-id":["S1525505024005973"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.110215","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association of polytherapy and psychiatric comorbidity in epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.110215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110215"}}